Quick Comparison

Methylene BlueOmega-3 (DHA)
Half-Life5-6 hours20-67 hours (plasma), but brain DHA turns over slowly over weeks
Typical DosageNootropic dose: 0.5-2 mg/kg body weight (typically 30-60 mg for most adults). Pharmaceutical grade USP only — never use industrial or aquarium-grade. Start at the lowest dose. Turns urine blue/green (harmless).Standard: 1-2 g combined EPA/DHA daily (aim for at least 500 mg DHA). For depression: 1-2 g EPA-dominant fish oil. Triglyceride form is better absorbed than ethyl ester. Take with a fatty meal.
AdministrationOral (solution, capsules). Must be pharmaceutical/USP grade. Sublingual for faster absorption.Oral (softgels, liquid). Triglyceride or phospholipid forms preferred over ethyl ester for bioavailability. Take with food containing fat.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Methylene Blue

Methylene blue has a unique property: it acts as an alternative electron carrier in the mitochondrial electron transport chain, cycling between oxidized (blue) and reduced (leuco) forms. It can accept electrons from Complex I (NADH) and donate them directly to cytochrome c, bypassing dysfunctional Complex II and III—maintaining ATP production when mitochondria are damaged or in hypoxic conditions. Methylene blue inhibits nitric oxide synthase (NOS), reducing NO production and the formation of peroxynitrite (ONOO-), a potent oxidant that damages mitochondria. It acts as a redox cycler with antioxidant properties and may enhance cytochrome c oxidase (Complex IV) activity. At low doses, it inhibits tau protein aggregation and tau-tau interactions (relevant to Alzheimer's pathology) and may improve mitochondrial respiration through multiple mechanisms.

Omega-3 (DHA)

DHA is a structural component of neuronal phospholipids (particularly phosphatidylethanolamine and phosphatidylserine in synaptic membranes), maintaining membrane fluidity which is essential for G-protein-coupled receptor function, ion channel gating, and synaptic vesicle fusion. DHA is metabolized by 15-lipoxygenase to specialized pro-resolving mediators (SPMs) including neuroprotectin D1 (NPD1), which actively resolve neuroinflammation by reducing NF-kappaB activation and pro-inflammatory cytokine production. DHA supports BDNF expression through modulation of the CREB pathway and promotes synaptic plasticity by enhancing long-term potentiation (LTP) and dendritic spine density. It also influences neurotransmitter receptor conformation and binding efficiency. Deficiency impairs membrane signaling, increases neuroinflammation, and accelerates cognitive decline.

Risks & Safety

Methylene Blue

Common

Blue/green discoloration of urine and potentially skin at higher doses, nausea, headache.

Serious

Serotonin syndrome risk when combined with SSRIs, SNRIs, or MAOIs — DO NOT combine. Contraindicated in G6PD deficiency (can cause hemolytic anemia).

Rare

Confusion, shortness of breath, chest pain.

Omega-3 (DHA)

Common

Fishy aftertaste, burping, mild gastrointestinal discomfort.

Serious

High doses (>3 g/day) may increase bleeding risk — caution with blood thinners. Fish oil quality matters — choose products tested for mercury and oxidation.

Rare

Allergic reaction in people with fish/shellfish allergy.

Full Profiles